With no clear end in sight to the COVID-19 pandemic, the fluctuations that we’ve been experiencing across the healthcare treatment and delivery continuum are likely here to stay. The question is, what does that mean for pharma companies and their key stakeholders? To get to the heart of the matter, we surveyed more than 500 patients and 500 physicians a few times throughout the last eight months. During this webinar, ZS expert Yasasvi Popuri shares industry trends, insights and implications gleaned from the results to ensure that you continue to create a positive customer experience during these uncertain times.
This webinar explores:
- Patients and physicians identify some of the critical challenges that they face along the care continuum.
- How patients and physicians feel about a potential COVID-19 vaccine and what it could mean for delivery of care, including whether in-person vs. telehealth visits are best.
- Customers share their changing engagement preferences and notions of how pharma can provide support.